Diabetes, Obesity & Metabolism
Hospitalisation Is a Strong Risk Factor for Discontinuation of Sodium-Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes
Study in peoplePopulations
Papers by Richard Osborne Day
2 results
- ADA Scientific Sessions 2025 Abstract
Hospitalization Is a Risk Factor for SGLT2i Discontinuation
Study in peoplePopulations